Understanding Mesothelioma Starts Here

Independent research, treatment information, and advocacy for patients and families facing a mesothelioma diagnosis.

~3,000 Annual U.S. Diagnoses
73% 1-Year Survival Rate
30% Are Veterans
Live Data

Active Clinical Trials

Find mesothelioma clinical trials currently recruiting patients. Data updated automatically from ClinicalTrials.gov.

Browse All Trials →
93 Recruiting
32 Immunotherapy
5 CAR-T Cell
52 U.S. Sites

Updated: Jan 27, 2026

Mesothelioma By The Numbers

~3,000 Annual U.S. Cases CDC/SEER 2024
73% 1-Year Survival NIH
12% 5-Year Survival SEER
38 years Average Latency CDC
View Full Statistics →
Special Report

The Talcum Powder Cancer Crisis

For decades, millions used talcum powder daily—unaware that some products contained asbestos. Today, over 90,000 lawsuits allege talc caused cancer.

90,000+ Lawsuits Filed
$10B+ In Verdicts
33% Increased Cancer Risk

Mesothelioma

From asbestos-contaminated talc. Average verdicts exceed $100 million.

Ovarian Cancer

From genital talc use. Over 50,000 cases filed.

Over $30 Billion in Trust Funds

60+ active asbestos trust funds continue paying claims. Average awards range from $300,000 to $400,000.

Time limits apply. Filing deadlines range from 1-6 years depending on your state.

Recent Verdicts

  • $1.56 Billion — J&J Talc, Baltimore (December 2025)
  • $966 Million — Mae Moore vs. J&J (2025)
  • $750 Million — Four Patients vs. J&J (2020)
Learn About Legal Options →

Why MesoWatch?

Independent Not affiliated with law firms or pharmaceutical companies
Comprehensive 183 articles, 47 occupation pages, 13 industry guides
Current Daily research monitoring with 58+ news stories
Medically Reviewed Expert physician oversight on all clinical content